5 Must-Read Analyst Questions From Bath and Body Works’s Q1 Earnings Call

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

BBWI Cover Image

Bath & Body Works’ first quarter results received a positive market reaction, reflecting stronger-than-expected profitability despite a decline in sales. Management attributed the quarter’s performance to early wins from its consumer-first formula, with CEO Daniel Heaf highlighting “strong product acceptance” in new hand soap launches and increased productivity in hero categories. However, body care underperformed due to planned changes in assortment and a heavier focus on accessories within collaborations. The company’s ongoing transformation efforts, including new product introductions and streamlined assortment, are beginning to show incremental improvements, even as broader business trends remain pressured.

Is now the time to buy BBWI? Find out in our full research report (it’s free for active Edge members).

Bath and Body Works (BBWI) Q1 CY2026 Highlights:

  • Revenue: $1.38 billion vs analyst estimates of $1.36 billion (3.2% year-on-year decline, 1.2% beat)
  • EPS (GAAP): $0.91 vs analyst estimates of $0.29 (significant beat)
  • Revenue Guidance for Q2 CY2026 is $1.49 billion at the midpoint, roughly in line with what analysts were expecting
  • EPS (GAAP) guidance for the full year is $3.13 at the midpoint, beating analyst estimates by 20.9%
  • Operating Margin: 16.8%, up from 14.7% in the same quarter last year
  • Locations: 2,502 at quarter end, up from 2,424 in the same quarter last year
  • Same-Store Sales fell 3.8% year on year (0.2% in the same quarter last year)
  • Market Capitalization: $3.77 billion

While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Bath and Body Works’s Q1 Earnings Call

  • Irwin Boruchow (Wells Fargo) asked about the turnaround in body care and whether the category’s issues were resolved; CEO Daniel Heaf described corrective actions taken and said early Q2 results are encouraging, but long-term growth will depend on innovation and assortment.
  • Matthew Boss (JPMorgan) inquired about lessons from the Amazon launch and channel balancing; Heaf emphasized Amazon’s effectiveness in acquiring new, younger customers and stated the owned channel will always have the broadest assortment.
  • Simeon Siegel (Guggenheim Securities) pushed for an explanation of declining sales—unit versus price—and customer frequency; Heaf and CFO Eva Boratto explained loyal customers are spending more, but growth depends on winning younger consumers and increasing units via innovation.
  • Lorraine Hutchinson (Bank of America) questioned the timing of a return to positive sales growth; Heaf replied that the company is not yet calling an inflection point, but expects a more visible impact from new launches in the second half.
  • Mark Altschwager (Baird) asked about maintaining promotional discipline amid a value-seeking customer base; Heaf indicated promotions will remain consistent year-over-year, prioritizing product-driven events over deeper discounts.

Catalysts in Upcoming Quarters

In future quarters, the StockStory team will closely monitor (1) the response to new product launches and the impact of body care assortment changes, (2) progress in digital channel upgrades and Amazon expansion, and (3) the effectiveness of store navigation improvements in driving conversion. Continued inflation and tariff trends will also be important to watch for their effect on margins.

Bath and Body Works currently trades at $18.59, up from $17.73 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free).

The Best Stocks for High-Quality Investors

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  250.02
-6.50 (-2.53%)
AAPL  310.26
-4.94 (-1.57%)
AMD  542.52
+20.98 (4.02%)
BAC  52.40
-0.08 (-0.15%)
GOOG  355.68
-2.71 (-0.76%)
META  622.98
+25.35 (4.24%)
MSFT  427.34
-13.97 (-3.17%)
NVDA  214.75
-8.07 (-3.62%)
ORCL  230.33
-14.25 (-5.83%)
TSLA  423.70
-0.04 (-0.01%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.